#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia chromosome positive Pleomorphic leiomyosarcoma Scleroderma associated digital ulcer Von Hippel-Lindau disease Hepatic angiosarcoma Liposarcoma Acute hepatic failure Alexander disease Keratosis follicular Idiopathic intracranial hypertension Hidradenitis Cytokine release syndrome Piriformis syndrome Waldenstrom's macroglobulinaemia recurrent Congenital hypotransferrinaemia More trials…

    Learn about Rare Diseases

    Systemic sclerosis pulmonary Hereditary motor and sensory neuropathy – Treatment Nephrotic syndrome – Basic Information Short-bowel syndrome – Life with Disease Breast angiosarcoma metastatic – Diagnostics Glycogen storage disease type II – Basic Information Hairy cell leukaemia recurrent – Treatment Undifferentiated sarcoma – Life with Disease Fabry’s disease – Diagnostics Leiomyosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Idarubicin Hypromellose Ublituximab REGN7544 Sumatriptan Succinate Naltrexone Hydrochloride Regn7257 GRNA1599 Fludrocortisone Acetate Lithium Sulphate, Anhydrous IBANDRONIC ACID Aavanc80-5'Hotof Tramadol Nirogacestat Hydrobromide IMEROPRUBART Insulin Lispro LY3848575 Staphylococcus Aureus ATTR-01 Sodium Alginate More therapies…

    Learn about Your Condition

    Endometrial adenocarcinoma Pain Ebola disease Microvillous inclusion disease Vascular graft thrombosis Low cardiac output syndrome Anal cancer recurrent Neuroendocrine tumour Thyroidectomy Epileptic encephalopathy Vaginal infection Lymphocytic leukaemia Adrenogenital syndrome Herpes virus infection Anal fistula More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness of Botulinum Toxin A and Sodium Chloride for Patients with Trigeminal Neuralgia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Trigeminal neuralgia
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Sodium Chloride
    Denmark

  • Study on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Italy Poland Spain

  • Study for Patients with Various Tumor Types Continuing Osimertinib Treatment After Previous Oncology Study Completion

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Osimertinib
    France Poland

  • Study on the Use of Romosozumab and Zoledronic Acid for Treating Osteoporosis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis
    Investigated Drugs:
    • Zoledronic Acid
    • Romosozumab
    Denmark

  • Study Comparing Chemoradiation and Chemotherapy with Cisplatin, Paclitaxel, and Carboplatin for Patients with Advanced Vulvar Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Vulval cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    Belgium Czechia The Netherlands Spain

  • Study of BMS-986340, Nivolumab, and Docetaxel for Adults with Advanced or Metastatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Bms-986340
    • Docetaxel
    • Nivolumab
    Germany Italy Spain
Previous Page
1 … 600 601 602 603 604 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!